MARTIN A MATTINGLY Insider Trading $ACHV ACHIEVE LIFE SCIENCES, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARTIN A MATTINGLY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARTIN A MATTINGLY. MARTIN A MATTINGLY is Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Exec. VP, Marketing & Bus. Dev in MICROMET, INC. ($MITI) and Director in Tracon Pharmaceuticals, Inc. ($TCON).
MARTIN A MATTINGLY in ACHIEVE LIFE SCIENCES, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of MARTIN A MATTINGLY: Director
Holdings: 10,500 shares
Current Value: $6,300
Latest Transaction: May 13 2021
$ACHV Market Capitalization: $18.31M
$ACHV Previous Close: $0.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARTIN A MATTINGLY in ACHIEVE LIFE SCIENCES, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHV, MITI, TCON
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | ACHV | ACHIEVE LIFE SCIEN ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 9.90 | 3,750 | 37,125 | 3,750 | |
| May 14 2020 | ACHV | ACHIEVE LIFE SCIEN ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 0.43 | 22,000 | 9,460 | 22,000 | |
| Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 2.56 | 12,000 | 30,720 | 12,000 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 4.57 | 11,000 | 50,270 | 11,000 | |
| May 27 2016 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 1.00 | 22,500 | 22,500 | 22,500 | |
| May 24 2016 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| May 24 2016 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Buy | M | 0.00 | 2,500 | 0 | 10,500 | 8 K to 10.5 K (+31.25 %) |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 1.89 | 5,000 | 9,450 | 5,000 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Buy | M | 0.00 | 2,500 | 0 | 8,000 | 5.5 K to 8 K (+45.45 %) |
Page: 1